Abrdn Healthcare Investors (HQH)
- Previous Close
16.05 - Open
16.05 - Bid 16.00 x 900
- Ask 16.47 x 1300
- Day's Range
16.05 - 16.15 - 52 Week Range
14.31 - 17.66 - Volume
84,193 - Avg. Volume
160,312 - Market Cap (intraday)
814.047M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
14.75 - EPS (TTM)
1.09 - Earnings Date --
- Forward Dividend & Yield 1.66 (10.32%)
- Ex-Dividend Date Feb 21, 2024
- 1y Target Est
--
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: HQH
Performance Overview: HQH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HQH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HQH
Valuation Measures
Market Cap
814.05M
Enterprise Value
--
Trailing P/E
14.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.30
Price/Book (mrq)
0.87
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
547.37%
Return on Assets (ttm)
-0.08%
Return on Equity (ttm)
6.10%
Revenue (ttm)
10.29M
Net Income Avi to Common (ttm)
56.33M
Diluted EPS (ttm)
1.09
Balance Sheet and Cash Flow
Total Cash (mrq)
214
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: HQH
HQH does not have Company Insights
Research Reports: HQH
Daily – Vickers Top Buyers & Sellers for 04/15/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/05/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/26/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/21/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.